1. Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
   Yubao Zhang et al, 2021, Frontiers in Pharmacology CrossRef
2. Molecular mechanisms of flavonoids and their modulatory effects against breast cancer: A scoping review
   Mary Murithi et al, 2022, F1000Research CrossRef
3. Integrative transcriptome analysis of triple negative breast cancer profiles for identification of druggable targets
   Poornima Arumugam et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
4. Administration of phytochemical nanoformulations (main routes of drug delivery)
   Souvik Ghosh et al, 2023, Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals CrossRef
5. Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase
   Shilpi Singh et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
6. Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer
   Pranaya Sankaranarayanan et al, 2024, F1000Research CrossRef
7. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations
   Aman Upaganlawar et al, 2022, Current Drug Metabolism CrossRef
8. The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers
   Xun Zhang et al, 2022, Frontiers in Genetics CrossRef
9. Bioluminescence Imaging-Based Assessment of the Anti-Triple-Negative Breast Cancer and NF-Kappa B Pathway Inhibition Activity of Britanin
   Xinyi Xu et al, 2020, Frontiers in Pharmacology CrossRef
10. Phytochemical‐Based Nanoparticles as Foes and Friends
    Charles Oluwaseun Adetunji et al, 2020, Poisonous Plants and Phytochemicals in Drug Discovery CrossRef
11. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
    Javed Ahmad et al, 2024, Expert Opinion on Drug Delivery CrossRef
12. A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy
    Pankaj Kumar et al, 2023, Frontiers in Pharmacology CrossRef
13. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer
    Yirivinti Hayagreeva Dinakar et al, 2023, AAPS PharmSciTech CrossRef
14. Geraniol and citral: recent developments in their anticancer credentials opening new vistas in complementary cancer therapy
    Gauri Srivastava et al, 2024, Zeitschrift für Naturforschung C CrossRef
15. Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells
    Prasath Manogaran et al, 2021, Cancer Investigation CrossRef
16. Antioxidant, Antiproliferative, Pro-apoptotic and cell cycle arrest properties of crude extract and biofractions of Hybanthus enneaspermus Linn. to combat breast cancer
    Liesl Maria Fernandese Mendonca et al, 2023, Research Journal of Pharmacy and Technology CrossRef
17. Potential anti-cancer activity of Moringa oleifera derived bio-active compounds targeting hypoxia-inducible factor-1 alpha in breast cancer
    Neha Masarkar et al, 2024, Journal of Complementary and Integrative Medicine CrossRef
18. Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells
    Soudeep Dey et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
19. Suppression of Molecular Targets and Antiproliferative Effect of Citronellal on Triple-Negative Breast Cancer Cells
    Kaneez Fatima et al, 2021, Current Molecular Pharmacology CrossRef